Myriad Genetics, Inc. (MYGN)

NASDAQ: MYGN · Real-Time Price · USD

6.14

+0.12 (1.99%)

Oct 27, 2026, 10:20 AM EDT - Market open

Myriad Genetics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	806.6	824.5	837.6	753.2	678.4	690.6
Revenue Growth	-3.16%	-1.56%	11.21%	11.03%	-1.77%	23.99%
Gross Profit	555.2	576.6	585.4	517	476.4	493
Operating Income	-90.5	-67.8	-88	-144.6	-123.7	-126.7
Net Income	-112.6	-365.9	-127.3	-263.3	-112	-27.2
Earnings Per Share	-1.20	-3.95	-1.41	-3.18	-1.39	-0.35
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Rest of world	53.9	56.5	68.1	81.5	86.9
United States	752.7	768	769.5	671.7	591.5
Total	806.6	824.5	837.6	753.2	678.4

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	115.2	149.6	102.4	140.9	169.7	397.8
Total Debt	210.5	209.8	140.3	152.1	145	92.3
Net Cash (Debt)	-95.3	-60.2	-37.9	-11.2	24.7	305.5
Net Cash Growth	-	-	-	-	-91.92%	-
Net Cash Per Share	-1.02	-0.65	-0.42	-0.14	0.31	3.92

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	7.7	1.8	-8.7	-110.9	-106.3	18.6
Capital Expenditures	-15	-15.6	-19	-63.2	-45.3	-18
Free Cash Flow	-7.3	-13.8	-27.7	-174.1	-151.6	0.6
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	68.83%	69.93%	69.89%	68.64%	70.22%	71.39%
Operating Margin	-11.22%	-8.22%	-10.51%	-19.20%	-18.23%	-18.35%
Pretax Margin	-13.86%	-47.92%	-14.74%	-34.81%	-20.73%	-8.27%
Profit Margin	-13.96%	-44.38%	-15.20%	-34.96%	-16.51%	-3.94%
FCF Margin	-0.91%	-1.67%	-3.31%	-23.11%	-22.35%	0.09%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	196.49	141.34	247.70	230.87	139.81
P/FCF Ratio	-	-	-	-	-	3673.31
PS Ratio	0.71	0.70	1.49	2.25	1.73	3.19